We are live on ! Find out more
RXD icon

ProShares UltraShort Health Care
RXD

3 hedge funds and large institutions have $776K invested in ProShares UltraShort Health Care in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

181% more capital invested

Capital invested by funds: $276K → $776K (+$500K)

70% more call options, than puts

Call options by funds: $11.9M | Put options by funds: $7.02M

3.54% more ownership

Funds ownership: 4.48% → 8.01% (+3.5%)

0% more funds holding

Funds holding: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
2
Calls
$11.9M
Puts
$7.02M
Net Calls
+$4.9M
Net Calls Change
-$9.22M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$491K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$287K

Top Sellers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$214K
2
UBS Group
UBS Group
Switzerland
-$16.9K
3
LTFS
Ladenburg Thalmann Financial Services
Florida
-$2K

RXD Hedge Fund Activity: Q1 2019 in Review

3 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q1 2019, worth a combined $776K — up 181% from $276K a quarter earlier.

Fund positioning in RXD was balanced in Q1 2019: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $491K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $214K sold.

  • 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $776K of ProShares UltraShort Health Care stock for Q1 2019, up 181% quarter-over-quarter.
  • 2 funds opened new ProShares UltraShort Health Care positions in Q1 2019 and 2 closed out, a net change of 0 holders.
  • The largest ProShares UltraShort Health Care buyer in Q1 2019 was Citadel Advisors, an estimated $491K added.
  • The largest ProShares UltraShort Health Care seller in Q1 2019 was Envestnet Asset Management, an estimated $214K sold.

Based on aggregated 13F filings for Q1 2019.